Tianjin TEDA Biomedical Engineering Company Limited reported earnings results for the second quarter and six months ended June 30, 2023. For the second quarter, the company reported sales was CNY 99.49 million compared to CNY 116.01 million a year ago. Net loss was CNY 5.37 million compared to CNY 7.2 million a year ago. Basic loss per share from continuing operations was CNY 0.00284 compared to CNY 0.0038 a year ago.
For the six months, sales was CNY 185.92 million compared to CNY 205.21 million a year ago. Net loss was CNY 11.25 million compared to CNY 13.25 million a year ago. Basic loss per share from continuing operations was CNY 0.00594 compared to CNY 0.00699 a year ago.